Aclaris Therapeutics, Inc. (ACRS) Form 10-K Annual Reports
Aclaris Therapeutics, Inc. (ACRS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACRS
CIK: 1557746
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerWilliam Liva
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-09-21 | — | SCHEDULE 13G Filing | 0001231919-26-001199 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001231919-26-000915 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001104659-26-092128 | View SEC Doc Filr Page |
| S-3ASR | 2026-08-06 | — | S-3ASR | 0001104659-26-092113 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-092065 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001104659-26-091629 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-08-01 | 4 Filing | 0002076327-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001590102-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001172252-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001674278-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001654773-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001187159-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001280044-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | 8-K | 0001104659-26-070494 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0001213900-26-055376 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001104659-26-057202 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001104659-26-056669 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | 4 Filing | 0002065269-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-28 | 8-K | 0001104659-26-049733 | View SEC Doc Filr Page |
| 4 | 2026-04-27 | 2026-04-27 | 4 Filing | 0001373604-26-000034 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-27 | — | SCHEDULE 13G/A Filing | 0001373604-26-000033 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001104659-26-047264 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001104659-26-047263 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2026-06-04 | DEF 14A | 0001104659-26-047262 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-07 | — | SCHEDULE 13G Filing | 0001346824-26-000099 | View SEC Doc Filr Page |